1. Home
  2. SLS vs SMHI Comparison

SLS vs SMHI Comparison

Compare SLS & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • SMHI
  • Stock Information
  • Founded
  • SLS 2012
  • SMHI 1989
  • Country
  • SLS United States
  • SMHI United States
  • Employees
  • SLS N/A
  • SMHI N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • SMHI Marine Transportation
  • Sector
  • SLS Health Care
  • SMHI Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • SMHI Nasdaq
  • Market Cap
  • SLS 169.6M
  • SMHI 139.9M
  • IPO Year
  • SLS N/A
  • SMHI N/A
  • Fundamental
  • Price
  • SLS $1.85
  • SMHI $5.87
  • Analyst Decision
  • SLS
  • SMHI
  • Analyst Count
  • SLS 0
  • SMHI 0
  • Target Price
  • SLS N/A
  • SMHI N/A
  • AVG Volume (30 Days)
  • SLS 3.6M
  • SMHI 127.5K
  • Earning Date
  • SLS 08-12-2025
  • SMHI 07-30-2025
  • Dividend Yield
  • SLS N/A
  • SMHI N/A
  • EPS Growth
  • SLS N/A
  • SMHI N/A
  • EPS
  • SLS N/A
  • SMHI N/A
  • Revenue
  • SLS N/A
  • SMHI $264,089,999.00
  • Revenue This Year
  • SLS N/A
  • SMHI N/A
  • Revenue Next Year
  • SLS N/A
  • SMHI $11.59
  • P/E Ratio
  • SLS N/A
  • SMHI N/A
  • Revenue Growth
  • SLS N/A
  • SMHI N/A
  • 52 Week Low
  • SLS $0.77
  • SMHI $3.63
  • 52 Week High
  • SLS $2.27
  • SMHI $15.36
  • Technical
  • Relative Strength Index (RSI)
  • SLS 52.48
  • SMHI 53.17
  • Support Level
  • SLS $1.88
  • SMHI $5.38
  • Resistance Level
  • SLS $2.27
  • SMHI $5.79
  • Average True Range (ATR)
  • SLS 0.17
  • SMHI 0.28
  • MACD
  • SLS -0.00
  • SMHI -0.01
  • Stochastic Oscillator
  • SLS 52.60
  • SMHI 67.39

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.

Share on Social Networks: